BQST
Bioquest Corp
Key Financials
Operating Income
$-817920
↑ 62.8%
EPS (Diluted)
$-0.06
N/A
Total Assets
$33540.00
↑ 96.2%
Net Income
$-821022
↑ 64.7%
Total Liabilities
$466530.00
↓ 73.9%
Shareholders' Equity
$-432990.00
↑ 75.5%
Cash & Equivalents
$33540.00
↑ 12800.0%
Operating Cash Flow
$-116720.00
↑ 39.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 253G2 | 10/8/2024 | View on SEC |
| 1-U | 8/28/2024 | View on SEC |
| QUALIF | 8/21/2024 | View on SEC |
| CORRESP | 8/19/2024 | View on SEC |
| CORRESP | 7/30/2024 | View on SEC |
| 1-A/A | 7/26/2024 | View on SEC |
| UPLOAD | 7/15/2024 | View on SEC |
| CORRESP | 7/1/2024 | View on SEC |
| 1-A/A | 7/1/2024 | View on SEC |
| UPLOAD | 6/11/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BQST |
| Company Name | Bioquest Corp |
| CIK | 1568628 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0430 |
| State of Incorporation | NV |
| Phone | 418-264-7134 |